BIGLARI HOLDINGS INC-B (BH) Stock Fundamental Analysis

NYSE:BH • US08986R3093

396.75 USD
-1.9 (-0.48%)
At close: Feb 13, 2026
396.75 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Fundamental Rating

3

BH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 126 industry peers in the Hotels, Restaurants & Leisure industry. While BH has a great health rating, there are worries on its profitability. BH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • BH had positive earnings in the past year.
  • In the past year BH had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: BH reported negative net income in multiple years.
  • In the past 5 years BH always reported a positive cash flow from operatings.
BH Yearly Net Income VS EBIT VS OCF VS FCFBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

  • BH's Return On Assets of 0.19% is on the low side compared to the rest of the industry. BH is outperformed by 61.83% of its industry peers.
  • The Return On Equity of BH (0.36%) is comparable to the rest of the industry.
  • BH has a Return On Invested Capital of 2.19%. This is in the lower half of the industry: BH underperforms 66.41% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BH is significantly below the industry average of 10.53%.
Industry RankSector Rank
ROA 0.19%
ROE 0.36%
ROIC 2.19%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
BH Yearly ROA, ROE, ROICBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

  • BH's Profit Margin of 0.54% is in line compared to the rest of the industry. BH outperforms 42.75% of its industry peers.
  • BH has a Operating Margin (6.19%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of BH has grown nicely.
  • With a Gross Margin value of 38.28%, BH is not doing good in the industry: 65.65% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of BH has grown nicely.
Industry RankSector Rank
OM 6.19%
PM (TTM) 0.54%
GM 38.28%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
BH Yearly Profit, Operating, Gross MarginsBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BH is destroying value.
  • Compared to 1 year ago, BH has about the same amount of shares outstanding.
  • The number of shares outstanding for BH has been reduced compared to 5 years ago.
  • Compared to 1 year ago, BH has a worse debt to assets ratio.
BH Yearly Shares OutstandingBH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
BH Yearly Total Debt VS Total AssetsBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • BH has an Altman-Z score of 2.64. This is not the best score and indicates that BH is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of BH (2.64) is better than 70.23% of its industry peers.
  • BH has a debt to FCF ratio of 3.77. This is a good value and a sign of high solvency as BH would need 3.77 years to pay back of all of its debts.
  • BH has a better Debt to FCF ratio (3.77) than 80.92% of its industry peers.
  • BH has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of BH (0.48) is better than 67.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.77
Altman-Z 2.64
ROIC/WACC0.26
WACC8.28%
BH Yearly LT Debt VS Equity VS FCFBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

  • BH has a Current Ratio of 2.83. This indicates that BH is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 2.83, BH belongs to the best of the industry, outperforming 92.37% of the companies in the same industry.
  • BH has a Quick Ratio of 2.80. This indicates that BH is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.80, BH belongs to the top of the industry, outperforming 93.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 2.8
BH Yearly Current Assets VS Current LiabilitesBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

0

3. Growth

3.1 Past

  • BH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.31%.
  • The Revenue has been growing slightly by 6.87% in the past year.
  • BH shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.55% yearly.
EPS 1Y (TTM)-94.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.77%
Revenue 1Y (TTM)6.87%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%10.32%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BH Yearly Revenue VS EstimatesBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
BH Yearly EPS VS EstimatesBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 -2 -4 -6 -8

2

4. Valuation

4.1 Price/Earnings Ratio

  • BH is valuated quite expensively with a Price/Earnings ratio of 77.79.
  • BH's Price/Earnings ratio is in line with the industry average.
  • BH is valuated expensively when we compare the Price/Earnings ratio to 26.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 77.79
Fwd PE N/A
BH Price Earnings VS Forward Price EarningsBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • BH's Enterprise Value to EBITDA is on the same level as the industry average.
  • 90.84% of the companies in the same industry are more expensive than BH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.15
EV/EBITDA 11.62
BH Per share dataBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • BH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BIGLARI HOLDINGS INC-B

NYSE:BH (2/13/2026, 8:04:00 PM)

After market: 396.75 0 (0%)

396.75

-1.9 (-0.48%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-07
Earnings (Next)02-27
Inst Owners93.18%
Inst Owner Change-1.9%
Ins Owners0.4%
Ins Owner Change0%
Market Cap904.59M
Revenue(TTM)386.51M
Net Income(TTM)2.09M
Analysts43.33
Price TargetN/A
Short Float %43.56%
Short Ratio1.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 77.79
Fwd PE N/A
P/S 2.34
P/FCF 11.15
P/OCF 8.44
P/B 1.56
P/tB 1.79
EV/EBITDA 11.62
EPS(TTM)5.1
EY1.29%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)35.59
FCFY8.97%
OCF(TTM)47.01
OCFY11.85%
SpS169.52
BVpS254.51
TBVpS221.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number170.89
Profitability
Industry RankSector Rank
ROA 0.19%
ROE 0.36%
ROCE 2.55%
ROIC 2.19%
ROICexc 3.61%
ROICexgc 4.17%
OM 6.19%
PM (TTM) 0.54%
GM 38.28%
FCFM 20.99%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
ROICexc(3y)5.11%
ROICexc(5y)4.86%
ROICexgc(3y)5.84%
ROICexgc(5y)5.56%
ROCE(3y)5.05%
ROCE(5y)4.78%
ROICexgc growth 3Y-14.08%
ROICexgc growth 5Y44.59%
ROICexc growth 3Y-14.03%
ROICexc growth 5Y43.14%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.77
Debt/EBITDA 4.35
Cap/Depr 64.86%
Cap/Sales 6.74%
Interest Coverage 250
Cash Conversion 167.28%
Profit Quality 3878.39%
Current Ratio 2.83
Quick Ratio 2.8
Altman-Z 2.64
F-Score4
WACC8.28%
ROIC/WACC0.26
Cap/Depr(3y)72.81%
Cap/Depr(5y)99.4%
Cap/Sales(3y)7.64%
Cap/Sales(5y)9.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.87%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%10.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.66%
EBIT growth 3Y-14.29%
EBIT growth 5Y33.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.75%
FCF growth 3Y-51.22%
FCF growth 5Y-24.16%
OCF growth 1Y39.79%
OCF growth 3Y-39.9%
OCF growth 5Y-11.92%

BIGLARI HOLDINGS INC-B / BH FAQ

What is the fundamental rating for BH stock?

ChartMill assigns a fundamental rating of 3 / 10 to BH.


What is the valuation status for BH stock?

ChartMill assigns a valuation rating of 2 / 10 to BIGLARI HOLDINGS INC-B (BH). This can be considered as Overvalued.


How profitable is BIGLARI HOLDINGS INC-B (BH) stock?

BIGLARI HOLDINGS INC-B (BH) has a profitability rating of 3 / 10.


What is the financial health of BIGLARI HOLDINGS INC-B (BH) stock?

The financial health rating of BIGLARI HOLDINGS INC-B (BH) is 7 / 10.